Canada • TSX Venture Exchange • TSX-V:AVCR • CA0545211090
The current stock price of AVCR.CA is 0.07 CAD. In the past month the price increased by 40%. In the past year, price increased by 16.67%.
ChartMill assigns a technical rating of 7 / 10 to AVCR.CA. When comparing the yearly performance of all stocks, AVCR.CA turns out to be only a medium performer in the overall market: it outperformed 67.35% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to AVCR.CA. No worries on liquidiy or solvency for AVCR.CA as it has an excellent financial health rating, but there are worries on the profitability.
Over the last trailing twelve months AVCR.CA reported a non-GAAP Earnings per Share(EPS) of -0.02. The EPS decreased by -1820% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -122.49% | ||
| ROE | -125.89% | ||
| Debt/Equity | 0 |
Avricore Health, Inc. engages in the business of health data and point-of-care technologies. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2001-07-31. The firm is involved in the business of health data and point-of-care technologies. HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The firm offers tests for approximately 27 biomarkers with a focus on screening and managing chronic conditions, such as diabetes, heart disease and chronic kidney disease, as well as checking for common viral and bacterial infections. Its test menu includes total cholesterol, triglycerides, FRS, HbA1c, glucose, sodium, potassium, calcium, chloride, total CO2, COVID-19, Flu A, Flu B, and Strep A.
AVRICORE HEALTH INC
1120 - 789 West Pender Street
Vancouver BRITISH COLUMBIA V7X 1H7 CA
CEO: Hector Bremner
Employees: 0
Phone: 16047738943
Avricore Health, Inc. engages in the business of health data and point-of-care technologies. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2001-07-31. The firm is involved in the business of health data and point-of-care technologies. HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The firm offers tests for approximately 27 biomarkers with a focus on screening and managing chronic conditions, such as diabetes, heart disease and chronic kidney disease, as well as checking for common viral and bacterial infections. Its test menu includes total cholesterol, triglycerides, FRS, HbA1c, glucose, sodium, potassium, calcium, chloride, total CO2, COVID-19, Flu A, Flu B, and Strep A.
The current stock price of AVCR.CA is 0.07 CAD. The price decreased by -6.67% in the last trading session.
AVCR.CA does not pay a dividend.
AVCR.CA has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
AVRICORE HEALTH INC (AVCR.CA) operates in the Health Care sector and the Health Care Technology industry.
AVRICORE HEALTH INC (AVCR.CA) currently has 0 employees.